Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease

Blood. 2009 Oct 22;114(17):3718-9; author reply 3719-20. doi: 10.1182/blood-2009-07-231159.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter

MeSH terms

  • Adult
  • Benzamides
  • Chronic Disease
  • Female
  • Graft vs Host Disease / drug therapy*
  • Graft vs Host Disease / pathology
  • Humans
  • Imatinib Mesylate
  • Lung Diseases / complications*
  • Lung Diseases / therapy
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation
  • Pilot Projects
  • Piperazines / therapeutic use*
  • Prospective Studies
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / therapeutic use*
  • Salvage Therapy
  • Treatment Outcome
  • Young Adult

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases